Deutsche Bank lowered the firm’s price target on Sanofi (SNY) to EUR 85 from EUR 90 and keeps a Sell rating on the shares.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SNY:
- AstraZeneca (AZN) Sees Its Cancer Drug Added to China’s Reimbursement List
- Sanofi (SNY) Is Seeking to Change How It Gives Discounts to Hospitals
- Sanofi planning changes to 340B hospital drug discount plan, WSJ reports
- Sanofi’s Sarclisa Nears EU Approval for Myeloma
- Regeneron, Sanofi announce FDA accepts Dupixent sBLA for review